10,794 press releases indexed under finance.
Predominantly third-line pancreatic cancer patients demonstrated durable survival despite advanced disease; patient who received Namodenoson as second-line therapy remains alive more than 18 months
Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET
NASHVILLE, Tenn., July 20, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the presentation of three studies supporting IHEEZO ® (chloroprocaine HCl ophthalmic gel 3%), a broadly labeled low viscosity ocular anesthetic gel, and BYOOVIZ ® (ranibizumab-nuna) i , an FDA-approved biosimilar referencing LUCENTIS ii (ranibizumab) at the American Society of Retina Specialists (ASRS) 2026 Annual Meeting. Collectively, the presentations expand the growing body of clinical and real-world evidence supporting Harrow's retina portfolio and reinforce Harrow’s commitment to generating quality evidence that strengthens physician confidence, improves patient experience, and supports long-term product adoption an
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced that it has raised its year-end AI Cloud annualized run-rate revenue (“ARR”) 1 target from $3.7bn to more than $4bn 2 , of which approximately 85% is now under contract following new multi-year cloud services contracts with leading AI developers representing $2.8bn in total contract value.
NORWALK, Conn., July 20, 2026 /PRNewswire/ -- Terex Corporation (NYSE: TEX) will host a conference call to review its second quarter 2026 financial results on Thursday, July 30, 2026 at 8:30 a.m. Eastern Time. Simon Meester, President and Chief Executive Officer, and Jennifer...
Barbara Humpton to retire and Thras Moraitis to become CEO, both effective October 1, 2026
LONDON and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced the filing of its Annual Report on Form 20-F for the fiscal year ended March 31, 2026, with the U.S. Securities and Exchange Commission (SEC). The report is available on the SEC’s website and the Company’s investor relations page. In conjunction with the filing, the Company provided a positive corporate update on its financial strength and clinical momentum.
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / July 20, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Microsoft Corporation (NASDAQ:MSFT) securities. If you suffered a loss on your Microsoft Corporation investment and would like to explore a potential recovery under the federal securities laws, Learn about Microsoft Corporation Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Microsoft Corporation that ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / July 20, 2026 /NEW YORK, NY / ACCESS Newswire / July 20, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ:ADMA) securities. If you suffered a loss on your ADMA Biologics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about ADMA Biologics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder ..
SINGAPORE, July 20, 2026 (GLOBE NEWSWIRE) -- Concorde International Group Ltd. (Nasdaq: YOOV) (the "Company") today issued the following correction to its announcement regarding its Nasdaq ticker symbol change.
FARNBOROUGH, England, July 20, 2026 (GLOBE NEWSWIRE) --
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / July 20, 2026 /SMX (Security Matters) Plc (NASDAQ:SMX) today announced its financial results for the six months ended June 30, 2026, highlighting a significantly strengthened balance sheet, improved liquidity and continued execution of its global commercialization strategy. First Half 2026 Highlights: US$50.5 million raised during H1 2026 pursuant to its existing SEPA program. Cash and cash equivalents increased to US$34.5 million. Payables and loans reduced by 61% to US$8.7 million. Shareholders' equity increased 181% to US$54.4 million. Continued expansion across Singapore, the UAE and Japan. Ongoing investment in Circular Economy, Plastic Credit Token (PCT), cyber hardware authentication and digital asset ..